4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000109
Chief Medical Officer sold 1,160 shares at $17.24 ($19,998)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Geffner Michael Chief Medical Officer | 2025-07-09 | Sale | −1,160 | $17.24 | $19,998 | 224,210 | D |
| Open-market sales · 1,160 sh · avg $17.24 · $19,998 | |||||||
Loading xslF345X05/wk-form4_1752264894.xml…